About the Metabolism and Cancer: Novel Therapeutic Targets Session
Targeting cancer metabolism has emerged as a promising therapeutic approach, particularly in the context of novel drug discovery. Metabolic alterations in cancer cells support their growth, survival, and resistance to treatment. Researchers are investigating how metabolic pathways, such as those involved in glucose uptake, fatty acid oxidation, and amino acid metabolism, can be modulated to disrupt cancer cell function. Targeting metabolic enzymes or signaling pathways could sensitize tumors to chemotherapy, immunotherapy, or radiation, potentially overcoming resistance mechanisms. By identifying specific metabolic vulnerabilities in cancer cells, researchers hope to design more effective and less toxic therapies that selectively target the altered metabolism of cancer cells, offering hope for patients with hard-to-treat cancers.
Topics Covered in Metabolism and Cancer: Novel Therapeutic Targets
Glycolytic Enzyme Targets
Glutaminase Inhibitors
Mutant IDH Inhibitors
Fatty Acid Oxidation
Amino Acid Depletion
Immunometabolism
Related Scientific Sessions at CIOC 2027
Why Attend the Metabolism and Cancer: Novel Therapeutic Targets Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Metabolism and Cancer: Novel Therapeutic Targets work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Metabolism and Cancer: Novel Therapeutic Targets research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Metabolism and Cancer: Novel Therapeutic Targets track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Metabolism and Cancer: Novel Therapeutic Targets Conference 2027 — FAQs
What is the Metabolism and Cancer: Novel Therapeutic Targets track at CIOC 2027?
The Metabolism and Cancer: Novel Therapeutic Targets track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Metabolism and Cancer: Novel Therapeutic Targets. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Metabolism and Cancer: Novel Therapeutic Targets sessions?
Cancer researchers and clinicians, educators and students with an interest in Metabolism and Cancer: Novel Therapeutic Targets are all welcome — whether presenting or attending.
Can I present my research in the Metabolism and Cancer: Novel Therapeutic Targets track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Metabolism and Cancer: Novel Therapeutic Targets sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Metabolism and Cancer: Novel Therapeutic Targets track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.